Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Ceftazidime

A third-generation cephalosporin patented in 1978 and in use since 1984, one of the few in its class active against Pseudomonas aeruginosa: it is used for serious infections and is the first-choice treatment for melioidosis. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.

Did you know?It shares its side chain with an antibiotic from another family, the monobactam aztreonam; its charged pyridinium group makes it more soluble in water.

CeftazidimeGo to the active ingredient →
CeftazidimeActive ingredientCeftazidimeCat. No. P-C100-001CAS 72558-82-8

EDQM standards 1

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.